Varga et al. confirmed that the overexpression of NOTCH3 enhanced tumor invasion and metastasis, and positively correlated with tumor grading, lymph node metastasis and distant metastasis, suggesting that NOTCH3 was a therapeutic target for CRC 36. The gene discussed is NOTCH3; the disease is colorectal carcinoma.